Streetbeat News

Earnings

SRI

Stoneridge, Inc. (NYSE:SRI) reported Q4 2023 adjusted earnings per share (EPS) of $0.12, surpassing the consensus estimate of $0.10 by 20%. However, its quarterly sales of $229.50 million fell short of the expected $233.10 million by 1.54%, marking a 0.74% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:17 pm

SDRL

Seadrill (NYSE:SDRL) reported Q4 earnings of $0.95 per share, surpassing the $0.66 estimate, marking a 306.52% increase from last year. Sales reached $408M, beating the $383.16M estimate, a 78.95% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:17 pm

RXST

RxSight projects its FY24 revenue to be between $128M and $135M, surpassing the estimated $126.957M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:16 pm

EFXT

Enerflex announced its Q4 sales at $574.57M, attributing the strong results to the continued performance of its recurring businesses.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:15 pm

CBAY

CymaBay Therapeutics reported Q4 EPS of $(0.35), missing the consensus estimate of $(0.31) by 12.9%. This represents a 16.67% increase in losses compared to the same period last year.

Portfolio Pulse from Happy Mohamed

February 28, 2024 | 10:15 pm

GRIN

Grindrod Shipping Holdings (GRIN) reported Q4 2023 adjusted EPS of $(0.14), surpassing the $(0.17) estimate. Sales reached $88.78M, exceeding the $40.25M forecast by 120.58% and marking a 9.11% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:15 pm

USPH

US Physical Therapy (USPH) reported Q4 2023 adjusted EPS of $0.59, surpassing the $0.57 estimate, and sales of $154.80M, exceeding the $150.27M estimate. This represents a 1.72% increase in EPS and a 9.65% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:14 pm

CSTL

Castle Bioscience projects its FY24 revenue to be between $235 million and $240 million, compared to its previous year's revenue of $214.693 million.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:14 pm

LPSN

LivePerson (NASDAQ:LPSN) reported Q4 2023 earnings with a GAAP EPS of $(0.48), missing the $(0.31) estimate, but sales of $95.47M exceeded the $94.13M forecast. This represents a 12.73% decrease in losses per share compared to last year, but a 22.05% drop in sales from the same period.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:12 pm

WW

WW International Inc. (NASDAQ:WW) reported Q4 adjusted losses per share of $1.11 and sales of $206 million, missing estimates slightly. Oprah Winfrey will not seek re-election to the board but plans to continue advocating for health equity and obesity awareness. She will donate her WW stock to the National Museum of African American History and Culture. WW shares fell 22.15% after-hours to $2.97.

Portfolio Pulse from Erica Kollmann

February 28, 2024 | 10:12 pm